# Yaser Mohammed Al‐Worafi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yaser-mohammed-al-worafi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 53,700 |
| Field | Pharmaceutical Practices and Patient Outcomes |
| h-index | 117 |
| i10-index | 141 |
| Last Known Institution | College of Medical Sciences |
| OpenAlex ID | https://openalex.org/A5025581939 |
| ORCID iD | https://orcid.org/0000-0002-5752-2913 |
| Works | 1,030 |

## Researcher papers

- [Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-incidence-prevalence-years-lived-with-disability-ylds-disability-adjusted/)
- [Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-prevalence-of-adult-overweight-and-obesity-1990/)
- [Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-incidence-and-mortality-burden-of-non-covid-19/)
- [A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists](https://scholariq.org/papers/a-qualitative-insight-into-the-perceptions-and-covid-19-vaccine-hesitancy-among/)
- [Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023](https://scholariq.org/papers/global-regional-and-national-burden-of-chronic-kidney-disease-in-adults-1990/)
- [Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-burden-of-epilepsy-1990-2021-a-systematic-analysis/)
- [Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021](https://scholariq.org/papers/global-regional-and-national-burden-of-asthma-and-atopic-dermatitis-1990-2021/)
- [Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021](https://scholariq.org/papers/forecasting-the-effects-of-smoking-prevalence-scenarios-on-years-of-life-lost/)

## Researcher topics

- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Complementary and Alternative Medicine Studies](https://scholariq.org/topics/complementary-and-alternative-medicine-studies/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Innovations in Medical Education](https://scholariq.org/topics/innovations-in-medical-education/)
- [Global Maternal and Child Health](https://scholariq.org/topics/global-maternal-and-child-health/)

## Researcher university

- [College of Medical Sciences](https://scholariq.org/institutions/college-of-medical-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.